HLF Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of HLF Antibodies for research focused on understanding Hepatic Leukemia Factor (HLF). HLF Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLF functions as a transcription factor with crucial roles in liver development and function, while also regulating various genes involved in hematopoiesis and immune responses. Research has shown that HLF expression patterns significantly impact liver diseases and various cancer types, making it an important focus in therapeutic studies. Understanding HLF activity provides valuable insights into cellular processes and disease mechanisms. Investigating HLF expression patterns helps reveal its role in normal development and disease progression. Researchers can utilize specific monoclonal antibodies to track HLF localization and expression levels across different tissue types and experimental conditions. Santa Cruz Biotechnology monoclonal antibodies for HLF support researchers worldwide in advancing scientific understanding of cellular regulation and disease mechanisms.